-
Conditions
Interventions
Patients receive radiation five days per week,
total radiation fraction 25-
30 fraction.
Patients receive weekly chemotherapy such as cisplatin or carboplatin during radiation therapy,Patients receive radiation five days per week,
30 fraction.
Patients receive weekly chemotherapy such as cisplatin or carboplatin during radiation therapy
Patients receive weekly hyperthermia during radiation therapy
concurrent chemoradiotherapy,concurrent chemoradiotherapy plus hyperthermia
Sponsors
Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy
Thermtech Medical Co.,
Ltd.
Eligibility
Sex/Gender
Female
Age
19 Years to No maximum
Inclusion criteria
Inclusion criteria: - CA cervix FIGO stage IB2, IIA2-IVA - Patho : squamous cell carcinoma, adenosquamous carcinoma or adenocarcinoma - Age more than 18 years - KPS > 70 - Treatment plan is concurrent chemoradiotherapy - No paraaortic lymph node metastasis - Adequate bone marrow and kidney function - No HIV history
Exclusion criteria
Exclusion criteria: - Patients have cardiac pacemaker or metal prosthesis in their body - Patients received abdominal radiotherapy or chemotherapy - Distant metastases - Previous malignancy, except adequately treated non-melanoma skin cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Treatment response rate at least 3 months after completion of treatment percentage and exact probability test | — |
Secondary
| Measure | Time frame |
|---|---|
| local relapse-free survival, disease-free survival, overall survival 2 year Kaplan Meier Statistical Analysis, Log-rank test | — |
Countries
Thailand
Contacts
Public ContactSunanta Rojwatkarnjana
Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy
Outcome results
None listed